These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21729761)

  • 41. Clinical and Safety Outcomes of Long-Term Azithromycin Therapy in Severe COPD Beyond the First Year of Treatment.
    Pomares X; Montón C; Bullich M; Cuevas O; Oliva JC; Gallego M; Monsó E
    Chest; 2018 May; 153(5):1125-1133. PubMed ID: 29427576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.
    Frantzi N; Nguyen XP; Herr C; Alter P; Söhler S; Soriano D; Watz H; Waschki B; Trinkmann F; Eichenlaub M; Trudzinski FC; Michels-Zetsche JD; Omlor A; Seiler F; Moneke I; Biertz F; Rohde G; Stolz D; Welte T; Kauczor HU; Kahnert K; Jörres RA; Vogelmeier CF; Bals R; Fähndrich S;
    Respir Res; 2024 May; 25(1):207. PubMed ID: 38750572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Balance and Falls in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Study.
    Oliveira CC; Lee AL; McGinley J; Anderson GP; Clark RA; Thompson M; Clarke S; Baker T; Irving LB; Denehy L
    COPD; 2017 Oct; 14(5):518-525. PubMed ID: 28745525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data.
    Halpin DM; Peterson S; Larsson TP; Calverley PM
    Respir Med; 2008 Nov; 102(11):1615-24. PubMed ID: 18691861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No significant detectable anti-infection effects of aspirin and statins in chronic obstructive pulmonary disease.
    Yayan J
    Int J Med Sci; 2015; 12(3):280-7. PubMed ID: 25798054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is the CAT questionnaire sensitive to changes in health status in patients with severe COPD exacerbations?
    Agustí A; Soler JJ; Molina J; Muñoz MJ; García-Losa M; Roset M; Jones PW; Badia X
    COPD; 2012 Aug; 9(5):492-8. PubMed ID: 22958111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations.
    Kodric M; Garuti G; Colomban M; Russi B; Porta RD; Lusuardi M; Confalonieri M
    Respirology; 2009 Apr; 14(3):424-8. PubMed ID: 19192230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome.
    Marin JM; Soriano JB; Carrizo SJ; Boldova A; Celli BR
    Am J Respir Crit Care Med; 2010 Aug; 182(3):325-31. PubMed ID: 20378728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit.
    Saleh A; López-Campos JL; Hartl S; Pozo-Rodríguez F; Roberts CM;
    PLoS One; 2015; 10(7):e0134004. PubMed ID: 26214175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subtypes of patients experiencing exacerbations of COPD and associations with outcomes.
    Arostegui I; Esteban C; García-Gutierrez S; Bare M; Fernández-de-Larrea N; Briones E; Quintana JM;
    PLoS One; 2014; 9(6):e98580. PubMed ID: 24892936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants of change in physical activity during moderate-to-severe COPD exacerbation.
    Esteban C; Quintana JM; Garcia-Gutierrez S; Anton-Ladislao A; Gonzalez N; Baré M; Fernández de Larrea N; Rivas-Ruiz F;
    Int J Chron Obstruct Pulmon Dis; 2016; 11():251-61. PubMed ID: 26893555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of statins on total cholesterol concentrations, cardiovascular morbidity, and all-cause mortality in chronic obstructive pulmonary disease: a population-based cohort study.
    Sheng X; Murphy MJ; MacDonald TM; Schembri S; Simpson W; Winter J; Winter JH; Wei L
    Clin Ther; 2012 Feb; 34(2):374-84. PubMed ID: 22244052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alterations in circulating mitochondrial signals at hospital admission for COPD exacerbation.
    Amado CA; Martín-Audera P; Agüero J; Ferrer-Pargada D; Josa Laorden B; Boucle D; Berja A; Lavín BA; Guerra AR; Ghadban C; Muñoz P; García-Unzueta M
    Chron Respir Dis; 2023; 20():14799731231220058. PubMed ID: 38112134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of Low-Dose versus High-Dose Continuous Cyclic Azithromycin Therapy for Preventing Acute Exacerbations of COPD.
    Pomares X; Montón C; Huertas D; Marín A; Cuevas E; Casabella A; Martí S; Oliva JC; Santos S
    Respiration; 2021; 100(11):1070-1077. PubMed ID: 34365450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The stats are in: an update on statin use in COPD.
    Carlson AA; Smith EA; Reid DJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2277-84. PubMed ID: 26543360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Studies of Statins in Asthma and COPD.
    Thomson NC
    Curr Mol Pharmacol; 2017; 10(1):60-71. PubMed ID: 26758945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk stratification for short-term mortality at hospital admission for acute exacerbations of COPD.
    Sprooten RTM; Rohde GGU; Lawyer G; Leijte WT; Wouters EFM; Franssen FME
    Respirology; 2019 Aug; 24(8):765-776. PubMed ID: 30897284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. One-year Mortality in COPD After an Exacerbation: The Effect of Physical Activity Changes During the Event.
    Esteban C; Garcia-Gutierrez S; Legarreta MJ; Anton-Ladislao A; Gonzalez N; Lafuente I; Fernandez de Larrea N; Vidal S; Bare M; Quintana JM; -Copd Group I
    COPD; 2016 Dec; 13(6):718-725. PubMed ID: 27285279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between P-pulmonale and respiratory morbidity in COPD: a secondary analysis of the BLOCK-COPD trial.
    Wade RC; Mkorombindo T; Ling SX; Helgeson ES; MacDonald DM; Pew K; Voelker H; Bittner V; Kunisaki KM; Lammi MR; Dransfield MT
    BMC Pulm Med; 2023 Nov; 23(1):434. PubMed ID: 37946165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.